--- title: "Forian (FORA.US)" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/FORA.US.md" symbol: "FORA.US" name: "Forian" industry: "Health Care Technology" datetime: "2026-05-20T06:01:57.038Z" locales: - [en](https://longbridge.com/en/quote/FORA.US.md) - [zh-CN](https://longbridge.com/zh-CN/quote/FORA.US.md) - [zh-HK](https://longbridge.com/zh-HK/quote/FORA.US.md) --- # Forian (FORA.US) ## Company Overview Forian Inc. provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure operational, clinical and financial performance. It develops commercial, real-world evidence (RWE), and market access solutions and proprietary data-driven insights. The company’s subscription and services-based solutions serve the life sciences, pharmaceutical services, healthcare payer, and provider and financial services industries. | Item | Detail | |------|--------| | Industry | Health Care Technology | | Exchange | US Market | ## Key Drivers > *AI-analyzed key factors driving this stock's performance* ## Longbridge Financial Score™: C > *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge* > Updated: 2026-05-20T04:30:15.000Z **Overall: C (0.44)** **Industry**: Health Care Technology | Metric | Value | |--------|-------| | Industry Ranking | 0 / 47 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. **Multi Score**: C #### Style Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 34.57% | | | Net Profit YoY | -38.70% | | | P/B Ratio | 0.00 | | | Dividend Ratio | 0.00% | | #### Size Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 0.00 | | | Revenue | 30051898.00 | | #### Multi Score Score: C | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -17.95% | E | | Profit Margin | -17.00% | D | | Gross Margin | 29.29% | C | | Revenue YoY | 34.57% | A | | Net Profit YoY | -38.70% | D | | Total Assets YoY | -20.14% | E | | Net Assets YoY | -10.52% | D | | Cash Flow Margin | -36.99% | E | | OCF YoY | 34.57% | A | | Turnover | 0.69 | B | | Gearing Ratio | 30.73% | B | ```chart-data:radar { "title": "Longbridge Financial Score - Forian", "chart_type": "radar", "dimensions": [ { "name": "Style Score", "grade": "", "indicators": [ { "name": "Revenue YoY", "value": "34.57%", "rating": "" }, { "name": "Net Profit YoY", "value": "-38.70%", "rating": "" }, { "name": "P/B Ratio", "value": "0.00", "rating": "" }, { "name": "Dividend Ratio", "value": "0.00%", "rating": "" } ] }, { "name": "Size Score", "grade": "", "indicators": [ { "name": "Market Cap", "value": "0.00", "rating": "" }, { "name": "Revenue", "value": "30051898.00", "rating": "" } ] }, { "name": "Multi Score", "grade": "C", "indicators": [ { "name": "ROE", "value": "-17.95%", "rating": "E" }, { "name": "Profit Margin", "value": "-17.00%", "rating": "D" }, { "name": "Gross Margin", "value": "29.29%", "rating": "C" }, { "name": "Revenue YoY", "value": "34.57%", "rating": "A" }, { "name": "Net Profit YoY", "value": "-38.70%", "rating": "D" }, { "name": "Total Assets YoY", "value": "-20.14%", "rating": "E" }, { "name": "Net Assets YoY", "value": "-10.52%", "rating": "D" }, { "name": "Cash Flow Margin", "value": "-36.99%", "rating": "E" }, { "name": "OCF YoY", "value": "34.57%", "rating": "A" }, { "name": "Turnover", "value": "0.69", "rating": "B" }, { "name": "Gearing Ratio", "value": "30.73%", "rating": "B" } ] } ] } ``` ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -23.59 | 35/47 | - | - | - | | PB | 2.28 | 24/47 | 2.25 | 2.13 | 2.07 | | PS (TTM) | 2.24 | 20/47 | 2.80 | 2.41 | 2.29 | | Dividend Yield | 0.00% | - | - | - | - | ## Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | | --- | --- | --- | --- | --- | --- | --- | --- | | 01 | QHSLab, Inc. (USAQ.US) | A | A | A | A | C | A | | 02 | Veeva Systems -CL (VEEV.US) | A | B | C | A | B | B | | 03 | Doximity (DOCS.US) | A | C | C | A | B | B | | 04 | Waystar (WAY.US) | B | A | D | B | B | B | | 05 | HeartFlow (HTFL.US) | B | A | B | A | B | B | ## Institutional View ### Analyst Rating Distribution > As of 2025-11-17T05:00:00.000Z Total Analysts: **1** | Rating | Count | Percentage | |--------|-------|-----------| | Hold | 1 | 100% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 2.16 | | Highest Target | 2.10 | | Lowest Target | 2.10 | ## References - [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/FORA.US/overview.md) - [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/FORA.US/norm.md) - [Related News](https://longbridge.com/en/quote/FORA.US/news.md) - [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/FORA.US/filings.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**